The United States Department of Defense has awarded a contract worth $US230 million ($302 million) to Brisbane-based biotech firm Ellume to ramp up production of its COVID-19 home test kits.
- The at-home tests are designed to detect fragments of the virus from a nasal swab
- It can be performed in 15 minutes with results reported via a smartphone app
- The test will be purchased without a prescription in the US, but not available in Australia
The money will allow increased production of…